Silence Therapeutics plc (FRA:XRP2)

Germany · Delayed Price · Currency is EUR

4.000

+0.180 (4.71%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
RNA Therapeutics	43.26M	31.64M	21.66M	16.81M	7.48M
RNA Therapeutics Growth	36.71%	46.12%	28.82%	124.73%	2214.81%
Total	43.26M	31.64M	21.66M	16.81M	7.48M
Total Growth	36.71%	46.12%	28.82%	124.73%	2214.81%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
UK	43.11M	30.93M	20.94M	16.28M	7.17M
UK Growth	39.37%	47.73%	28.63%	126.99%	3066.76%
Germany	144.00K	709.00K	715.00K	530.79K	308.56K
Germany Growth	-79.69%	-0.84%	34.70%	72.02%	219.15%
Total	43.26M	31.64M	21.66M	16.81M	7.48M
Total Growth	36.71%	46.12%	28.82%	124.73%	2214.81%

Source: S&P Global Market Intelligence.